Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 28, 2006

THE COOPER COMPANIES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   1-8597   94-2657368

(State or other jurisdiction

of incorporation)

  (Commission File Number)   (IRS Employer Identification No.)

6140 Stoneridge Mall Road, Suite 590, Pleasanton, California 94588

(Address of principal executive offices)

(925) 460-3600

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



ITEM 9.01. Financial Statements and Exhibits.

 

(a) Financial statements of businesses acquired.

 

Exhibit
No.
  

Description

99.1    Audited consolidated balance sheets of Ocular Sciences, Inc. and subsidiaries as of December 31, 2004 and 2003, and the related consolidated statements of income, stockholders’ equity and cash flows for each of the years in the three-year period ended December 31, 2004.

 

(d) Exhibits.

 

Exhibit
No.
  

Description

23    Consent of Independent Registered Public Accounting Firm.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

THE COOPER COMPANIES, INC.
By   /s/ Carol R. Kaufman

Carol R. Kaufman

Senior Vice President of Legal Affairs, Secretary and Chief Administrative Officer

Dated: April 28, 2006


EXHIBIT INDEX

 

Exhibit
No.
  

Description

23       Consent of Independent Registered Public Accounting Firm.
99.1    Audited consolidated balance sheets of Ocular Sciences, Inc. and subsidiaries as of December 31, 2004 and 2003, and the related consolidated statements of income, stockholders’ equity and cash flows for each of the years in the three-year period ended December 31, 2004.